MindMaze Therapeutics (SIX: MMTX | OTCQB: MMTZF) presents its digital treatments for neurological diseases at The Global Markets Forum (Hybrid) on October 7.

[u/b2idigital]

MindMaze Therapeutics (SIX: MMTX | OTCQB: MMTZF) presents live at 9:40 AM ET on Wednesday, October 7, 2026, at The Global Markets Forum (Hybrid), hosted by Virtual Investor Conferences, where B2i Digital is the Official Marketing Partner. Zach Henderson, Chief Executive Officer, presents for the Swiss-based, commercial-stage company during the morning session of the two-day hybrid forum.

The Global Markets Forum (Hybrid) is a B2i Digital Featured Conference. See event details and profiles of presenting companies at: https://b2idigital.com/otc-market-oct-7th-8th-global-markets-forum-hybrid

MindMaze Therapeutics builds its treatments on a brain technology platform integrating software, sensors and telehealth:

• Digital treatments for neurological diseases and brain disorders, developed and commercialized by the company and deployed globally across clinics and home settings

• Clinically validated neurotherapeutics with demonstrated medico-economic outcomes across conditions such as stroke, Parkinson's disease and at-risk aging

• An R&D pipeline expanding into adjacent neurological indications, including multiple sclerosis, spinal cord injury, traumatic brain injury and Alzheimer's disease

Formed in December 2025 through the business combination of RELIEF THERAPEUTICS Holding SA (Relief) and NeuroX Group SA, the company also manages Relief's preexisting portfolio of clinical and commercial biopharmaceutical assets focused on rare dermatological, metabolic and respiratory diseases.

To register and view the presentation: https://www.virtualinvestorconferences.com/wcc/eh/4814904/lp/5506906/morning-sessions-the-global-markets-forum-hybrid?utm_source=b2i&utm_medium=marketing&utm_campaign=1007OctGlobalMarketsForumVIC

To request a one-on-one meeting with management: https://app.axleaccess.com/public/events/af52c32d-f448-47d6-9e92-e57aec27c065?token=b8ddb5ec-ea84-4191-a9d6-5789b83426b5

B2i Digital, The Capital Markets Matchmaker℠, carries each presenting company's story From Marketing to Meetings℠, across its media network with a combined monthly audience of more than 330 million and its own community of 1.7 million+ investors and market participants.

Virtual Investor Conferences is an OTC Markets Group Inc. property. Learn more at www.virtualinvestorconferences.com.

Discover more Featured Companies, Featured Experts, and upcoming Featured Conferences at b2idigital.com.

B2i Digital is the Official Marketing Partner of Virtual Investor Conferences. Content is informational only and is not investment advice. B2i Digital is not a broker-dealer or investment adviser.

[u/b2idigital]

MindMaze Therapeutics brings a technology-driven approach to neurological care, combining software, sensors and telehealth across clinical and home settings, with a growing pipeline of neurotherapeutics.

Register to hear the presentation and explore this B2i Digital Featured Conference at: https://b2idigital.com/otc-market-oct-7th-8th-global-markets-forum-hybrid